NCT00835107 - An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Depression, Bipolar

Interventions

DRUG

ziprasidone hydrochloride

oral capsules, from 40-80 mg BID, for one month with the option to continue the medication after the study has been completed

DRUG

placebo

placebo comparator, oral capsules, BID, for one month

Trial Locations (1)

Providence Care Mental Health Services, Kingston